Analgesics
Antiandrogens
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Abstract
All quercetin studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchQuercetinQuercetin (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   

Exploring the Antiviral Potential of Esters of Cinnamic Acids with Quercetin

Manca et al., Viruses, doi:10.3390/v16050665
Apr 2024  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Quercetin for COVID-19
22nd treatment shown to reduce risk in July 2021
 
*, now known with p = 0.0031 from 11 studies.
No treatment is 100% effective. Protocols combine complementary and synergistic treatments. * >10% efficacy in meta analysis with ≥3 clinical studies.
4,100+ studies for 60+ treatments. c19early.org
In Vitro study showing that esters of cinnamic acids with quercetin, particularly ester 7, inhibit SARS-CoV-2 and hCoV-OC43 coronavirus infection in Vero-76 and Vero E6 cells. Mechanism of action studies suggest ester 7 may inhibit coronavirus infection by reducing viral attachment to host cells and blocking viral endocytosis. Authors propose these quercetin-cinnamic acid conjugates as potential coronavirus antivirals worthy of further investigation.
In Silico studies predict inhibition of SARS-CoV-2, or minimization of side effects, with quercetin or metabolites via binding to the spike Note A, Alavi, Azmi (B), Chandran, Kandeil, Mandal, Moschovou, Nguyen, Pan, Thapa (B), Şimşek, Mpro Note B, Akinwumi, Alanzi, Ibeh, Kandeil, Mandal, Moschovou, Nguyen, Qin, Rehman, Sekiou (B), Singh, Thapa (B), Wang, Zhang, Shaik, Waqas, Nalban, Irfan, RNA-dependent RNA polymerase Note C, Corbo, PLpro Note D, Ibeh, Zhang, ACE2 Note E, Chandran, Ibeh, Qin, Thapa (B), Şimşek, Alkafaas, TMPRSS2 Note F, Chandran, helicase Note G, Alanzi, Singh (B), endoribonuclease Note H, Alavi, cathepsin L Note I, Ahmed, Wnt-3 Note J, Chandran, FZD Note K, Chandran, LRP6 Note L, Chandran, ezrin Note M, Chellasamy, ADRP Note N, Nguyen, NRP1 Note O, Şimşek, EP300 Note P, Hasanah, PTGS2 Note Q, Qin, HSP90AA1 Note R, Qin, Hasanah, matrix metalloproteinase 9 Note S, Sai Ramesh, IL-6 Note T, Yang, Yang (B), IL-10 Note U, Yang, VEGFA Note V, Yang (B), and RELA Note W, Yang (B) proteins. In Vitro studies demonstrate efficacy in Calu-3 Note X, DiGuilio, A549 Note Y, Yang, HEK293-ACE2+ Note Z, Singh (C), Huh-7 Note AA, Pan, Caco-2 Note AB, Roy, Vero E6 Note AC, Kandeil, El-Megharbel, Roy, mTEC Note AD, Wu, and RAW264.7 Note AE, Wu cells. Animal studies demonstrate efficacy in K18-hACE2 mice Note AF, Aguado, db/db mice Note AG, Wu, Wu (B), BALB/c mice Note AH, Shaker, and rats El-Megharbel (B). Quercetin reduced proinflammatory cytokines and protected lung and kidney tissue against LPS-induced damage in mice Shaker.
Manca et al., 24 Apr 2024, peer-reviewed, 14 authors. Contact: mancavaleria26@gmail.com (corresponding author), vanessa.palmas@unica.it, aldomanzin@unica.it, annalisa.chianese@unicampania.it, carla.zannella@unicampania.it, mariavittoriamorone@gmail.com, massimiliano.galdiero@unicampania.it, federicaetzi@gmail.com, davide.moi2@gmail.com, gsarais@unica.it, vonnis@unica.it, fsecci@unica.it, gabriele.serreli@unica.it, g.sanna@unica.it.
In Vitro studies are an important part of preclinical research, however results may be very different in vivo.
This PaperQuercetinAll
Exploring the Antiviral Potential of Esters of Cinnamic Acids with Quercetin
Valeria Manca, Annalisa Chianese, Vanessa Palmas, Federica Etzi, Carla Zannella, Davide Moi, Francesco Secci, Gabriele Serreli, Giorgia Sarais, Maria Vittoria Morone, Massimiliano Galdiero, Valentina Onnis, Aldo Manzin, Giuseppina Sanna
Viruses, doi:10.3390/v16050665
Severe acute respiratory syndrome-related Coronavirus 2 (SARS-CoV-2) has infected more than 762 million people to date and has caused approximately 7 million deaths all around the world, involving more than 187 countries. Although currently available vaccines show high efficacy in preventing severe respiratory complications in infected patients, the high number of mutations in the S proteins of the current variants is responsible for the high level of immune evasion and transmissibility of the virus and the reduced effectiveness of acquired immunity. In this scenario, the development of safe and effective drugs of synthetic or natural origin to suppress viral replication and treat acute forms of COVID-19 remains a valid therapeutic challenge. Given the successful history of flavonoids-based drug discovery, we developed esters of substituted cinnamic acids with quercetin to evaluate their in vitro activity against a broad spectrum of Coronaviruses. Interestingly, two derivatives, the 3,4-methylenedioxy 6 and the ester of acid 7, have proved to be effective in reducing OC43-induced cytopathogenicity, showing interesting EC50s profiles. The ester of synaptic acid 7 in particular, which is not endowed with relevant cytotoxicity under any of the tested conditions, turned out to be active against OC43 and SARS-CoV-2, showing a promising EC 50 . Therefore, said compound was selected as the lead object of further analysis. When tested in a yield reduction, assay 7 produced a significant dose-dependent reduction in viral titer. However, the compound was not virucidal, as exposure to high concentrations of it did not affect viral infectivity, nor did it affect hCoV-OC43 penetration into pre-treated host cells. Additional studies on the action mechanism have suggested that our derivative may inhibit viral endocytosis by reducing viral attachment to host cells.
Conflicts of Interest: The authors declare no conflict of interest.
References
Adisakwattana, Pongsuwan, Wungcharoen, Yibchok-Anun, In Vitro Effects of Cinnamic Acid Derivatives on Protein Tyrosine Phosphatase 1B, J. Enzym. Inhib. Med. Chem, doi:10.3109/14756366.2012.715286
Ahmad, Kaleem, Ahmed, Shafiq, Therapeutic potential of flavonoids and their mechanism of action against microbial and viral infections-A review, Food Res. Int, doi:10.1016/j.foodres.2015.06.021
Amano, Yamashita, Kasai, Hori, Miyasato et al., Cinnamic acid derivatives inhibit hepatitis C virus replication via the induction of oxidative stress, Antivir. Res, doi:10.1016/j.antiviral.2017.07.018
Antonopoulou, Sapountzaki, Rova, Christakopoulos, Ferulic acid from plant biomass: A phytochemical with promising antiviral properties, Front. Nutr, doi:10.3389/fnut.2021.777576
Badshah, Faisal, Muhammad, Poulson, Emwas et al., Antiviral activities of flavonoids, Biomed. Pharmacother, doi:10.1016/j.biopha.2021.111596
Baj, Karakuła-Juchnowicz, Teresi Ński, Buszewicz, Ciesielka et al., COVID-19: Specific and Non-Specific Clinical Manifestations and Symptoms: The Current State of Knowledge, J. Clin. Med, doi:10.3390/jcm9061753
Balboni, Congiu, Onnis, Maresca, Scozzafava et al., Flavones and structurally related 4-chromenones inhibit carbonic anhydrases by a different mechanism of action compared to coumarins, Bioorg. Med. Chem. Lett, doi:10.1016/j.bmcl.2012.03.071
Bian, Guo, Majeed, Zhu, Guo et al., Ferulic acid renders protection to HEK293 cells against oxidative damage and apoptosis induced by hydrogen peroxide, Vitr. Cell. Dev. Biol.-Anim, doi:10.1007/s11626-015-9876-0
Chaachouay, Zidane, Plant-Derived Natural Products: A Source for Drug Discovery and Development, Drugs Drug Candidates, doi:10.3390/ddc3010011
Chen, Li, Pan, Lao, Xu et al., Cinnamic acid inhibits Zika virus by inhibiting RdRp activity, Antivir. Res, doi:10.1016/j.antiviral.2021.105117
Citarella, Dimasi, Moi, Passarella, Scala et al., Recent Advances in SARS-CoV-2 Main Protease Inhibitors: From Nirmatrelvir to Future Perspectives, Biomolecules, doi:10.3390/biom13091339
Citarella, Moi, Pedrini, Pérez-Peña, Pieraccini et al., Synthesis of SARS-CoV-2 Mpro inhibitors bearing a cinnamic ester warhead with in vitro activity against human coronaviruses, Org. Biomol. Chem, doi:10.1039/D3OB00381G
Cui, Xiao, Xu, Chen, Liu et al., Bioassay of ferulic acid derivatives as influenza neuraminidase inhibitors, Arch. Pharm, doi:10.1002/ardp.201900174
Detoma, Krishnamoorthy, Nam, Lee, Brender et al., Synthetic Flavonoids, Aminoisoflavones: Interaction and Reactivity with Metal-Free and Metal-Associated Amyloid-β Species, Chem. Sci, doi:10.1039/c4sc01531b
Dinda, Dinda, Dinda, Ghosh, Das, Anti-SARS-CoV-2, antioxidant and immunomodulatory potential of dietary flavonol quercetin: Focus on molecular targets and clinical efficacy, Eur. J. Med. Chem. Rep, doi:10.1016/j.ejmcr.2023.100125
Elebeedy, Elkhatib, Kandeil, Ghanem, Kutkat et al., Anti-SARS-CoV-2 activities of tanshinone IIA, carnosic acid, rosmarinic acid, salvianolic acid, baicalein, and glycyrrhetinic acid between computational and in vitro insights, RSC Adv, doi:10.1039/D1RA05268C
Fuzo, Martins, Fraga-Silva, Amstalden, Canassa De Leo et al., Celastrol: A lead compound that inhibits SARS-CoV-2 replication, the activity of viral and human cysteine proteases, and virus-induced IL-6 secretion, Drug Dev. Res, doi:10.1002/ddr.21982
Gao, Yu, Guo, Kong, Gu et al., The anticancer effects of ferulic acid is associated with induction of cell cycle arrest and autophagy in cervical cancer cells, Cancer Cell Int, doi:10.1186/s12935-018-0595-y
Ibba, Carta, Madeddu, Caria, Serreli et al., Inhibition of Enterovirus A71 by a Novel 2-Phenyl-Benzimidazole Derivative, Viruses, doi:10.3390/v13010058
Ibitoye, Ajiboye, Ferulic acid potentiates the antibacterial activity of quinolone-based antibiotics against Acinetobacter baumannii, Microb. Pathog, doi:10.1016/j.micpath.2018.11.033
Lalani, Poh, Flavonoids as Antiviral Agents for Enterovirus A71 (EV-A71), Viruses, doi:10.3390/v12020184
Lambruschini, Demori, El Rashed, Rovegno, Canessa et al., Synthesis, photoisomerization, antioxidant activity, and lipid Lowering effect of ferulic acid and feruloyl amides, Molecules, doi:10.3390/molecules26010089
Lan, Hou, Liu, Ding, Zhang et al., Design, synthesis and evaluation of novel cinnamic acid derivatives bearing N-benzyl pyridinium moiety as multifunctional cholinesterase inhibitors for Alzheimer's disease, J. Enzym. Inhib. Med. Chem, doi:10.1080/14756366.2016.1256883
Liu, Wei, Li, Liu, Cao et al., Design, synthesis, biological evaluation and molecular docking studies of phenylpropanoid derivatives as potent anti-hepatitis B virus agents, Eur. J. Med. Chem, doi:10.1016/j.ejmech.2015.03.056
Mao, Wang, Chen, Yan, Xun et al., synthesis, antiviral activities of ferulic acid derivatives, Front. Pharmacol, doi:10.3389/fphar.2023.1133655
Montaser, Huttunen, Ibrahim, Huttunen, Astrocyte-targeted transporter-utilizing derivatives of ferulic acid can have multifunctional effects ameliorating inflammation and oxidative stress in the brain, Oxidative Med. Cell. Longev, doi:10.1155/2019/3528148
Nićiforović, Abramovič, Sinapic Acid and Its Derivatives: Natural Sources and Bioactivity, Compr. Rev. Food Sci. Food Saf, doi:10.1111/1541-4337.12041
Pavlíková, Caffeic Acid and Diseases-Mechanisms of Action, Int. J. Mol. Sci, doi:10.3390/ijms24010588
Peng, Cheng, Gong, Yuan, Zhao et al., Advances in the design and development of SARS-CoV-2 vaccines, Mil. Med. Res, doi:10.1186/s40779-021-00360-1
Sanna, Farci, Busonera, Murgia, La Colla et al., Antiviral properties from plants of the Mediterranean flora, Nat. Prod. Res, doi:10.1080/14786419.2014.1003187
Serreli, Le Sayec, Thou, Lacour, Diotallevi et al., Ferulic Acid Derivatives and Avenanthramides Modulate Endothelial Function through Maintenance of Nitric Oxide Balance in HUVEC Cells, Nutrients, doi:10.3390/nu13062026
Theodosis-Nobelos, Kourti, Tziona, Kourounakis, Rekka, Esters of some non-steroidal anti-inflammatory drugs with cinnamyl alcohol are potent lipoxygenase inhibitors with enhanced anti-inflammatory activity, Bioorg. Med. Chem. Lett, doi:10.1016/j.bmcl.2015.10.036
Theodosis-Nobelos, Papagiouvannis, Rekka, Ferulic, Sinapic, 3,4-Dimethoxycinnamic Acid and Indomethacin Derivatives with Antioxidant, Anti-Inflammatory and Hypolipidemic Functionality, Antioxidants, doi:10.3390/antiox12071436
Ullah, Munir, Badshah, Khan, Ghani et al., Important Flavonoids and Their Role as a Therapeutic Agent, Molecules, doi:10.3390/molecules25225243
V'kovski, Kratzel, Steiner, Stalder, Thiel, Coronavirus biology and replication: Implications for SARS-CoV, Nat. Rev. Microbiol, doi:10.1038/s41579-020-00468-6
Yin, Zhang, Li, Shi, Jin et al., Ferulic acid inhibits bovine endometrial epithelial cells against LPS-induced inflammation via suppressing NK-κB and MAPK pathway, Res. Vet. Sci, doi:10.1016/j.rvsc.2019.08.018
Zannella, Giugliano, Chianese, Buonocore, Vitale et al., Antiviral Activity of Vitis vinifera Leaf Extract against SARS-CoV-2 and HSV-1, Viruses, doi:10.3390/v13071263
Zhou, Xu, Zhao, Chen, Jin et al., Ferulic acid relaxed rat aortic, small mesenteric and coronary arteries by blocking voltage-gated calcium channel and calcium desensitization via dephosphorylation of ERK1/2 and MYPT1, Eur. J. Pharmacol, doi:10.1016/j.ejphar.2017.10.008
Zhu, Scholle, Kisthardt, Xie, Flavonols and dihydroflavonols inhibit the main protease activity of SARS-CoV-2 and the replication of human coronavirus 229E, Virology, doi:10.1016/j.virol.2022.04.005
{ 'DOI': '10.3390/v16050665', 'ISSN': ['1999-4915'], 'URL': 'http://dx.doi.org/10.3390/v16050665', 'abstract': '<jats:p>Severe acute respiratory syndrome-related Coronavirus 2 (SARS-CoV-2) has infected ' 'more than 762 million people to date and has caused approximately 7 million deaths all around ' 'the world, involving more than 187 countries. Although currently available vaccines show high ' 'efficacy in preventing severe respiratory complications in infected patients, the high number ' 'of mutations in the S proteins of the current variants is responsible for the high level of ' 'immune evasion and transmissibility of the virus and the reduced effectiveness of acquired ' 'immunity. In this scenario, the development of safe and effective drugs of synthetic or ' 'natural origin to suppress viral replication and treat acute forms of COVID-19 remains a ' 'valid therapeutic challenge. Given the successful history of flavonoids-based drug discovery, ' 'we developed esters of substituted cinnamic acids with quercetin to evaluate their in vitro ' 'activity against a broad spectrum of Coronaviruses. Interestingly, two derivatives, the ' '3,4-methylenedioxy 6 and the ester of acid 7, have proved to be effective in reducing ' 'OC43-induced cytopathogenicity, showing interesting EC50s profiles. The ester of synaptic ' 'acid 7 in particular, which is not endowed with relevant cytotoxicity under any of the tested ' 'conditions, turned out to be active against OC43 and SARS-CoV-2, showing a promising EC50. ' 'Therefore, said compound was selected as the lead object of further analysis. When tested in ' 'a yield reduction, assay 7 produced a significant dose-dependent reduction in viral titer. ' 'However, the compound was not virucidal, as exposure to high concentrations of it did not ' 'affect viral infectivity, nor did it affect hCoV-OC43 penetration into pre-treated host ' 'cells. Additional studies on the action mechanism have suggested that our derivative may ' 'inhibit viral endocytosis by reducing viral attachment to host cells.</jats:p>', 'alternative-id': ['v16050665'], 'author': [ { 'affiliation': [ { 'name': 'Department of Biomedical Sciences, Microbiology and Virology ' 'Unit, University of Cagliari, Cittadella Universitaria, 09042 ' 'Monserrato, Italy'}], 'family': 'Manca', 'given': 'Valeria', 'sequence': 'first'}, { 'ORCID': 'http://orcid.org/0000-0002-1648-4519', 'affiliation': [ { 'name': 'Department of Experimental Medicine, University of Study of ' 'Campania “Luigi Vanvitelli”, Via Costantinopoli 16, 80138 ' 'Napoli, Italy'}], 'authenticated-orcid': False, 'family': 'Chianese', 'given': 'Annalisa', 'sequence': 'additional'}, { 'affiliation': [ { 'name': 'Department of Biomedical Sciences, Microbiology and Virology ' 'Unit, University of Cagliari, Cittadella Universitaria, 09042 ' 'Monserrato, Italy'}], 'family': 'Palmas', 'given': 'Vanessa', 'sequence': 'additional'}, { 'ORCID': 'http://orcid.org/0000-0003-4837-4477', 'affiliation': [ { 'name': 'Department of Biomedical Sciences, Biology and Genetic Unit, ' 'University of Cagliari, Cittadella Universitaria, 09042 ' 'Monserrato, Italy'}], 'authenticated-orcid': False, 'family': 'Etzi', 'given': 'Federica', 'sequence': 'additional'}, { 'ORCID': 'http://orcid.org/0000-0001-7991-8700', 'affiliation': [ { 'name': 'Department of Experimental Medicine, University of Study of ' 'Campania “Luigi Vanvitelli”, Via Costantinopoli 16, 80138 ' 'Napoli, Italy'}], 'authenticated-orcid': False, 'family': 'Zannella', 'given': 'Carla', 'sequence': 'additional'}, { 'ORCID': 'http://orcid.org/0000-0002-2470-9351', 'affiliation': [ { 'name': 'Department of Life and Environmental Sciences, University of ' 'Cagliari, Cittadella Universitaria, 09042 Monserrato, Italy'}], 'authenticated-orcid': False, 'family': 'Moi', 'given': 'Davide', 'sequence': 'additional'}, { 'ORCID': 'http://orcid.org/0000-0003-0443-2890', 'affiliation': [ { 'name': 'Department of Chemical and Geological Sciences, University of ' 'Cagliari, Cittadella Universitaria, 09042 Monserrato, Italy'}], 'authenticated-orcid': False, 'family': 'Secci', 'given': 'Francesco', 'sequence': 'additional'}, { 'ORCID': 'http://orcid.org/0000-0002-1971-3989', 'affiliation': [ { 'name': 'Department of Biomedical Sciences, Pathology Unit, University of ' 'Cagliari, Cittadella Universitaria, 09042 Monserrato, Italy'}], 'authenticated-orcid': False, 'family': 'Serreli', 'given': 'Gabriele', 'sequence': 'additional'}, { 'ORCID': 'http://orcid.org/0000-0002-6297-2687', 'affiliation': [ { 'name': 'Department of Life and Environmental Sciences, University of ' 'Cagliari, Cittadella Universitaria, 09042 Monserrato, Italy'}], 'authenticated-orcid': False, 'family': 'Sarais', 'given': 'Giorgia', 'sequence': 'additional'}, { 'ORCID': 'http://orcid.org/0009-0000-0810-8460', 'affiliation': [ { 'name': 'Department of Experimental Medicine, University of Study of ' 'Campania “Luigi Vanvitelli”, Via Costantinopoli 16, 80138 ' 'Napoli, Italy'}], 'authenticated-orcid': False, 'family': 'Morone', 'given': 'Maria Vittoria', 'sequence': 'additional'}, { 'ORCID': 'http://orcid.org/0000-0002-1576-6290', 'affiliation': [ { 'name': 'Department of Experimental Medicine, University of Study of ' 'Campania “Luigi Vanvitelli”, Via Costantinopoli 16, 80138 ' 'Napoli, Italy'}], 'authenticated-orcid': False, 'family': 'Galdiero', 'given': 'Massimiliano', 'sequence': 'additional'}, { 'ORCID': 'http://orcid.org/0000-0002-2438-725X', 'affiliation': [ { 'name': 'Department of Life and Environmental Sciences, University of ' 'Cagliari, Cittadella Universitaria, 09042 Monserrato, Italy'}], 'authenticated-orcid': False, 'family': 'Onnis', 'given': 'Valentina', 'sequence': 'additional'}, { 'ORCID': 'http://orcid.org/0000-0003-2961-3428', 'affiliation': [ { 'name': 'Department of Biomedical Sciences, Microbiology and Virology ' 'Unit, University of Cagliari, Cittadella Universitaria, 09042 ' 'Monserrato, Italy'}], 'authenticated-orcid': False, 'family': 'Manzin', 'given': 'Aldo', 'sequence': 'additional'}, { 'ORCID': 'http://orcid.org/0000-0002-3999-4263', 'affiliation': [ { 'name': 'Department of Biomedical Sciences, Microbiology and Virology ' 'Unit, University of Cagliari, Cittadella Universitaria, 09042 ' 'Monserrato, Italy'}], 'authenticated-orcid': False, 'family': 'Sanna', 'given': 'Giuseppina', 'sequence': 'additional'}], 'container-title': 'Viruses', 'container-title-short': 'Viruses', 'content-domain': {'crossmark-restriction': False, 'domain': []}, 'created': {'date-parts': [[2024, 4, 24]], 'date-time': '2024-04-24T14:18:36Z', 'timestamp': 1713968316000}, 'deposited': { 'date-parts': [[2024, 4, 24]], 'date-time': '2024-04-24T14:30:45Z', 'timestamp': 1713969045000}, 'funder': [ { 'award': ['PE00000007, INF-ACT'], 'name': 'NextGeneration EU-MUR PNRR Extended Partnership initiative on Emerging Infectious ' 'Diseases'}], 'indexed': {'date-parts': [[2024, 4, 25]], 'date-time': '2024-04-25T00:26:18Z', 'timestamp': 1714004778143}, 'is-referenced-by-count': 0, 'issue': '5', 'issued': {'date-parts': [[2024, 4, 24]]}, 'journal-issue': {'issue': '5', 'published-online': {'date-parts': [[2024, 5]]}}, 'language': 'en', 'license': [ { 'URL': 'https://creativecommons.org/licenses/by/4.0/', 'content-version': 'vor', 'delay-in-days': 0, 'start': { 'date-parts': [[2024, 4, 24]], 'date-time': '2024-04-24T00:00:00Z', 'timestamp': 1713916800000}}], 'link': [ { 'URL': 'https://www.mdpi.com/1999-4915/16/5/665/pdf', 'content-type': 'unspecified', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'member': '1968', 'original-title': [], 'page': '665', 'prefix': '10.3390', 'published': {'date-parts': [[2024, 4, 24]]}, 'published-online': {'date-parts': [[2024, 4, 24]]}, 'publisher': 'MDPI AG', 'reference-count': 0, 'references-count': 0, 'relation': {}, 'resource': {'primary': {'URL': 'https://www.mdpi.com/1999-4915/16/5/665'}}, 'score': 1, 'short-title': [], 'source': 'Crossref', 'subject': [], 'subtitle': [], 'title': 'Exploring the Antiviral Potential of Esters of Cinnamic Acids with Quercetin', 'type': 'journal-article', 'volume': '16'}
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit